No surprise really. RAP was pumped for this run with the investor report, which was no more than rehashed announcements put succinctly into a PowerPoint presentation.
>100% profit for some over the past 2 weeks and >50% profit for those who held when RAP listed. How many of those didn't take a nice profit this week and are still on board?
Good prelim results are already factored in the current SP IMO.
With no product launch for over 12 months and many hurdles before then RAP is a marathon, not a sprint. FDA approval will be the biggest hurdle and even a prelim meeting is still months away.
RAP is a potential fortune maker......but not any time soon
My reasons for a buy, page-108
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)